Actinium Pharmaceuticals Presents New Radiochemistry Data at SNMMI 2026 Demonstrating That CAR Optimization Improves Tumor Targeting and Pharmacokinetics of Actinium-225 Radioconjugates
Go back to Actinium Pharmaceuticals Presents New Radiochemistry Data at SNMMI 2026 Demonstrating That CAR Optimization Improves Tumor Targeting and Pharmacokinetics of Actinium-225 Radioconjugates| Actinium Pharmaceuticals, Inc. (NYSE: ATNM) | Delayed: 1.01 -0.03 (2.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.04 | 52 Week High | $3.50 | |||
| Open | $1.03 | 52 Week Low | $0.86 | |||
| Day High | $1.05 | P/E | N/A | |||
| Day Low | $1.00 | EPS | $-7.61 | |||
| Volume | 199,244 | |||||
